Hermal - Disposal Completed

3rd September 2007

                          Hermal - Disposal Completed                          

Reckitt Benckiser plc announces that, following the necessary regulatory
clearances in Germany, the sale of Hermal to Laboratorios Almirall S.A., the
Spanish based international pharmaceutical company, for a consideration of £255
million in cash has been completed.

Reckitt Benckiser plc has been advised by Goldman Sachs.

For Further Information

Tom Corran Reckitt Benckiser [phone]

Senior Vice President, Investor Relations & Corporate Communications

Fiona Fong Reckitt Benckiser [phone]

Head of Corporate Communications